DRACP01734 |
SB-37 AC |
MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG |
38 |
FLAK peptides |
DRACP01735 |
SB-37 AM |
MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG |
38 |
FLAK peptides |
DRACP01736 |
FLAK 17 CV |
VAKALAKALLKALKAL |
16 |
FLAK peptides |
DRACP01737 |
FLAK50 Q1V |
VAKFLAKFLKKAL |
13 |
FLAK peptides |
DRACP01738 |
D2A21V |
VAKKFAKKFKKFAKKFAKFAFAF |
23 |
FLAK peptides |
DRACP01739 |
FLAK26V AM |
VAKKLAKLAKKLAKLAL |
17 |
FLAK peptides |
DRACP01740 |
FLAK 25 AM V |
VAKKLAKLAKKLAKLALAL |
19 |
FLAK peptides |
DRACP01741 |
FLAK43 AM V |
VAKKLAKLAKKLLAL |
15 |
FLAK peptides |
DRACP01742 |
FLAK50D V |
VAKLLAKALKKLL |
13 |
FLAK peptides |
DRACP01743 |
FLAK50V |
VAKLLAKLAKKLL |
13 |
FLAK peptides |
DRACP01744 |
FLAK50T8 |
VAKLLAKLAKKVL |
13 |
FLAK peptides |
DRACP01745 |
Hecate AC V |
VALALKALKKALKKLKKALKKAL |
23 |
FLAK peptides |
DRACP01746 |
Hecate AM V |
VALALKALKKALKKLKKALKKAL |
23 |
FLAK peptides |
DRACP01747 |
KAL V |
VALALKALKKALKKLKKALKKAL |
23 |
FLAK peptides |
DRACP01748 |
FLAK-120G |
VALALKALKKL |
11 |
FLAK peptides |
DRACP01749 |
FLAK04 AM V |
VALALKALKKLAKKLKKLAKKAL |
23 |
FLAK peptides |
DRACP01750 |
FLAK-120F |
WALAL |
5 |
FLAK peptides |
DRACP01751 |
FLAK50T9 |
YAKLLAKLAKKAL |
13 |
FLAK peptides |
DRACP01752 |
pDBD * 4R9 |
YLCAGRNDCIIAIKFEEKTAQHAAIENVFRLERRRRRRRRR |
41 |
Synthetics |
DRACP01753 |
DDA-DL6K6-22 |
lKKllKKllKKl |
12 |
Synthetic |
DRACP01754 |
DDA-DL6R6-25 |
lRRllRRllRRl |
12 |
Synthetic |
DRACP01755 |
DL6K6 |
lKKllKKllKKl |
12 |
Synthetic |
DRACP01756 |
MA-DL6K6-23 |
lKKllKKllKKl |
12 |
Synthetic |
DRACP01757 |
PA-DL6K6-24 |
lKKllKKllKKl |
12 |
Synthetic |
DRACP01758 |
SEQ ID NO: 4 |
WRYMVm |
6 |
Not available |
DRACP01759 |
Sequence 1 from Patent US 20060100147 |
YLCAGRNDCIIAIKFEEKTAQHAAIENVFRLE |
32 |
Synthetic construct |
DRACP01760 |
pep1 |
EARPALLTSRLRFIPK |
16 |
Not available |
DRACP01761 |
AQTGTGKT |
AQTGTGKT |
8 |
Synthetics |
DRACP01762 |
D-AQTGTGKT |
D-AQTGTGKT |
10 |
Synthetics |
DRACP01763 |
Not available |
GTGKA |
5 |
Not available |